XCX.CN Greenrise Global (CNQ) +100% Market Hours Feb 11, 2026: liquidity risk

XCX.CN stock led today’s top gainers on the CNQ, jumping 100.00% to C$0.01 during market hours on 11 Feb 2026. The move followed a low-volume trade of 1,000 shares versus an average volume of 21,010, which highlights extreme thin liquidity for Greenrise Global Brands Inc. (XCX.CN). Market participants should note the company’s small market cap of C$516,554, negative EPS of -0.03, and a trailing PE of -0.33 while interpreting the spike. Meyka AI, an AI-powered market analysis platform, flags volatility and sector weakness in Healthcare as key context for the price action.

XCX.CN stock: intraday price action and liquidity

Greenrise Global Brands Inc. (XCX.CN) opened at C$0.01 and traded only at that price range today, producing a 100.00% one-day change on CNQ with volume of 1,000 shares. Average volume is 21,010, so the trade represents low participation and high execution risk for new buyers.

XCX.CN stock: fundamentals and valuation

XCX.CN shows a tiny market cap of C$516,554, 51,655,400 shares outstanding, EPS of -0.03, and a negative PE of -0.33, reflecting ongoing losses and limited revenue disclosure. Price averages are 50-day C$0.0061 and 200-day C$0.00603, while the 52-week range runs from C$0.005 to C$0.025, indicating wide historical swings.

XCX.CN stock: technical read

Technical indicators show an RSI near 47.31, ADX at 41.16 indicating a strong trend signal, and Bollinger Bands squeezed at C$0.01. Given the tiny ATR and zero-price dispersion today, technical moves are likely driven by block trades rather than sustained market interest.

XCX.CN stock: Meyka AI grade and analyst view

Meyka AI rates XCX.CN with a score out of 100: 65.23 (Grade B), suggestion HOLD. This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. These grades are informational only and are not guarantees or personal financial advice.

XCX.CN stock: catalysts, risks and sector context

Greenrise operates as a medical cannabis supplier to German pharmacies in the Healthcare sector, which has shown a 1D performance drag of -8.84% and weak 6M trends. Primary risks are extremely low liquidity, limited cash per share (C$0.00021), negative book value per share (-C$0.05554), and sparse public news flow. Potential catalysts would be confirmed EU-GMP supply wins, improved sales in Germany, or corporate filings that restore investor confidence.

XCX.CN stock: trading checklist and price targets

For traders, use limit orders only and expect wide spreads; position sizes should be small relative to portfolio. Meyka AI’s model and market context suggest a conservative near-term price target range of C$0.005–C$0.03, with C$0.03 as an optimistic technical target and C$0.005 as downside support near the 52-week low.

Final Thoughts

XCX.CN stock’s 100.00% intraday jump to C$0.01 on 11 Feb 2026 highlights how tiny-cap Healthcare names can move sharply on thin volume. The company’s fundamentals—EPS -0.03, negative book value per share -C$0.05554, and market cap C$516,554—underscore structural risk. Meyka AI’s forecast model projects a yearly baseline of C$0.01931, implying ~93.10% upside from C$0.01, but this projection is model-based and not a guarantee. Traders face both upside from re-rating and downside from low liquidity and limited disclosures. Given the stock’s low float, small trades can swing price rapidly; we recommend strict risk controls, tiny position sizes, and watching for validated corporate updates. For detailed snapshots and live alerts, see our XCX.CN page on Meyka for real-time metrics and the comparison data from Investing for trade confirmation source. Forecasts are model-based projections and not guarantees.

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.